Gain Therapeutics
GANX
GANX
12 hedge funds and large institutions have $15M invested in Gain Therapeutics in 2021 Q1 according to their latest regulatory filings, with 12 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
12
Holders Change
+12
Holders Change %
–
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
GC
1
Greenlight Capital
New York
| $8.16M | 546,560 | +546,560 | New |
|
|
GPCM
2
Granite Point Capital Management
Boston,
Massachusetts
| $3.36M | 225,000 | +225,000 | New |
|
|
ACM
3
AIGH Capital Management
Baltimore,
Maryland
| $982K | 65,809 | +65,809 | New |
|
|
PCM
4
Prelude Capital Management
New York
| $867K | 58,100 | +58,100 | New |
|
|
MS
5
Maven Securities
St Helier,
Jersey
| $340K | 22,124 | +22,124 | New |
|
6
Jane Street
New York
| $339K | 22,754 | +22,754 | New |
|
|
WVP
7
Worth Venture Partners
Fort Lee,
New Jersey
| $232K | 15,532 | +15,532 | New |
|
|
DKCM
8
Davidson Kempner Capital Management
New York
| $222K | 15,000 | +15,000 | New |
|
9
Millennium Management
New York
| $214K | 14,367 | +14,367 | New |
|
|
MA
10
MYDA Advisors
Woodmere,
New York
| $209K | 14,000 | +14,000 | New |
|
11
UBS Group
Zurich,
Switzerland
| $91K | 6,105 | +6,105 | New |
|
12
Morgan Stanley
New York
| $12K | 800 | +800 | New |
|
|
CFGS
13
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|